


Dr. Peter Nigrovic, MD
Dr. Peter Nigrovic, MD is a rheumatologist in Boston, MA and has over 25 years of experience in the medical field. He graduated from HARVARD Medical School in 1995. He is affiliated with Boston Children's Hospital. He is accepting new patients and telehealth appointments.
Division of Immunology
300 Longwood Ave # 6 Boston, MA 02115At a Glance
- Areas of ExpertiseDr. Nigrovic specializes in the areas of Pediatric Rheumatology & Rheumatology. • See board certifications
- Explains Conditions Well
- Offers TelehealthThis doctor offers telehealth appointments. Call the office to schedule an appointment.
- Trustworthy

Save money with free prescription discounts
Experience Check
Search for experience in a specific area
Insurance Check
Search for your insurance carrier and choose your plan type
Dr. Nigrovic's Reviews
Likelihood to recommend Dr. Nigrovic
5 star | 83% | 83% |
4 star | 0% | 0% |
3 star | 0% | 0% |
2 star | 0% | 0% |
1 star | 17% | 17% |
Your trust is our top concern.
We strive to keep reviews honest, trustworthy, and fair.Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
- Office environment
- Listened & answered questions
- Explained conditions well
- Staff friendliness
- Appointment wasn't rushed
- Trusted the provider's decisions
- Wait times
- Office environment
- Appointment scheduling
- Listened & answered questions
- Explained conditions well
- Staff friendliness
- Appointment wasn't rushed
- Trusted the provider's decisions
- Wait times
- Office environment
- Appointment scheduling
- Listened & answered questions
- Explained conditions well
- Staff friendliness
- Appointment wasn't rushed
- Trusted the provider's decisions
- Wait times
Leave a review
How was your experience with Dr. Nigrovic?Overall Patient Satisfaction
Likelihood of recommending Dr. Nigrovic to family and friends is 4.3333335 out of 5
About Me
biography
Dr. Peter Nigrovic is an Assistant in Medicine in the Department of Rheumatology at Boston Children's Hospital. He specializes in Immunodeficiency, Adult & Pediatric Rheumatology Immunology, and Kawasaki Disease.Dr. Nigrovic received...read more
Rheumatology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Brigham & Women's Hospital
Fellowship Hospital, 2009Boston Children's Hospital
Fellowship Hospital, 2004Boston Children's Hospital|brigham & Women's Hospital
Fellowship Hospital, 2004Massachusetts General Hospital
Residency Hospital, 1999Massachuestts General Hospital
Internship Hospital, 1996Harvard Medical School
Medical School, 1995Amherst College
Undergraduate School, 1989
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkEnglish
Spanish
AMIGO: a novel approach to the mentorship gap in pediatric rheumatology, 2019-10-05
Megakaryocyte emperipolesis: a new frontier in cell-in-cell interaction, 2019-11-21
A multidisciplinary assessment of pain in juvenile idiopathic arthritis, 2021-06-04
IgG Fc glycosylation as an axis of humoral immunity in childhood, 2019-10-24
21stCentury Storm Chasers: Defining Macrophage Activation Syndrome, 2019-10-05
Disease characteristics and medication use in a multicenter cohort of children with juvenile idiopathic arthritis (JIA): preliminary analyses from the CARRAnet registry, 2012-07-13
Age and fecal microbial strain-specific differences in patients with spondyloarthritis, 2018-01-30
Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease, 2019-03-04
Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis, 2022-01-15
Storm warning: lung disease in systemic juvenile idiopathic arthritis, 2019-09-22
Proceedings of the 23rdPaediatric Rheumatology European Society Congress: part one Genoa, Italy. 28 September-01 October 2016, 2017-05-30
Subpopulations Within Juvenile Psoriatic Arthritis: A Review of the Literature, 2006-01-01
Weekly Adalimumab, an Effective Alternative for Refractory Uveitis in Children, 2022-01-01
Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2, 2018-06-21
Effects of estradiol on biological age measured using the glycan age index, 2020-10-13
Biological classification of childhood arthritis: roadmap to a molecular nomenclature, 2021-03-17
Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis, 2018-02-23
Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis, 2023-01-05
Building an ARC to grant success: The Aims Review Committee, 2017-03-03
Consensus Treatment Plans for New-Onset Systemic Juvenile Idiopathic Arthritis, 2012-02-04
Toward personalized treatment for systemic juvenile idiopathic arthritis, 2018-06-29
The metabolic regulator mTORC1 controls terminal myeloid differentiation, 2017-05-26
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans, 2022-12-08
Arthritis flares mediated by tissue-resident memory T cells in the joint, 2021-10-26
Differential responsiveness of monocyte and macrophage subsets to interferon, 2019-12-10
The Rheumatoid Arthritis Risk Variant CCR6DNP RegulatesCCR6via PARP-1, 2016-09-14
Interleukin-33 Primes Mast Cells for Activation by IgG Immune Complexes, 2012-10-11
Correction: Stoll et al. Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients.Children2022,9, 569, 2022-08-02
Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis, 2012-07-13
Genetics and the classification of arthritis in adults and children, 2017-12-01
Healthgrades Tips for Getting the Best Rheumatology Care
Locations
Division of Immunology
Affiliated Hospitals
Compare Providers
Providers shown based on Dr. Nigrovic's location and specialty. Show more Rheumatologists.